Dose of transplanted blood-forming stem cells affects their behavior

May 25, 2016 by Cristy Lytal, University of Southern California
Clockwise from top left: Study authors Casey Brewer, Elizabeth Chu, Rong Lu and Mike Chin Credit: Cristy Lytal

Unlike aspirin, bone marrow doesn't come with a neatly printed label with dosage instructions. However, a new study published in Cell Reports provides clues about how the dose of transplanted bone marrow might affect patients undergoing this risky procedure, frequently used to treat cancer and blood diseases.

In the study, USC Stem Cell researcher Casey Brewer and colleagues in the laboratory of Rong Lu found that transplantation dose affects the behavior of in —called , or HSCs.

To track these cells' behavior, the researchers "barcoded" individual mouse HSCs with a genetic marker and observed their contributions to forming blood.

Every HSC is capable of acting as a generalist, producing all of the specialized types of following bone marrow transplantation. However, the researchers observed that only 20 to 30 percent of HSCs took on this generalist role, contributing all of the most abundant types of white blood cells—called granulocytes, B cells and T cells. This relatively small group of generalist HSCs produced a disproportionately large amount of blood.

The remaining 70 to 80 percent of HSCs were more strategic. When facing a scarcity of transplanted bone marrow at the lowest dose, these HSCs prioritized T cell production. At higher transplantation doses, these HSCs opted to differentiate early, producing a balanced array of T cells and B cells.

"The dose of transplanted bone marrow has strong and lasting effects on how HSCs specialize and coordinate their behavior," said Rong Lu, senior author and assistant professor of and regenerative medicine. "This suggests that altering transplantation dose could be a tool for improving outcomes for patients—promoting bone marrow engraftment, reducing the risk of infection and ultimately saving lives."

Explore further: Blood stem cells study could pave the way for new cancer therapy

More information: Casey Brewer et al, Transplantation Dose Alters the Differentiation Program of Hematopoietic Stem Cells, Cell Reports (2016). DOI: 10.1016/j.celrep.2016.04.061

Related Stories

Blood stem cells study could pave the way for new cancer therapy

March 10, 2016
People with leukaemia could be helped by new research that sheds light on how the body produces its blood supply.

Study uncovers key player contributing to healthy maintenance of bone marrow niche

February 17, 2016
A study led by scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has uncovered a key player contributing to the maintenance of hematopoietic stem cells ...

Researchers poke around for blood genes

July 10, 2015
Even though the transplantation of blood stem cells, also known as bone marrow, has saved many lives over many decades, the genes that control the number or function of blood stem cells are not fully understood. In a study ...

Conditions that promote proliferation of blood-forming cells in fetal liver

January 11, 2016
A study directed by Paul Frenette, M.D., is featured on the cover of today's print edition of Science. In experiments involving mice, Dr. Frenette and his colleagues have solved a mystery surrounding the development of hematopoietic ...

Stem cells regulate their own proliferation and their microenvironment

January 8, 2016
A study by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) has identified a new mechanism through which hematopoietic stem cells (HSCs) control both their own proliferation and the ...

Researchers unlock protein key to harnessing regenerative power of blood stem cells

December 10, 2014
(Medical Xpress)—UCLA scientists have for the first time identified a protein that plays a key role in regulating how blood stem cells replicate in humans.

Recommended for you

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.